Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)
Taiwan · Delayed Price · Currency is TWD 36.85
-0.15 (-0.41%)
At close: Mar 6, 2026
Nang Kuang Pharmaceutical Revenue
In the year 2025, Nang Kuang Pharmaceutical had annual revenue of 2.16B TWD, down -1.71%. Nang Kuang Pharmaceutical had revenue of 517.20M in the quarter ending December 31, 2025, a decrease of -10.71%.
Revenue
2.16B
Revenue Growth
-1.71%
P/S Ratio
1.72
Revenue / Employee
3.92M
Employees
552
Market Cap
3.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.16B | -37.64M | -1.71% |
| Dec 31, 2024 | 2.20B | 49.63M | 2.31% |
| Dec 31, 2023 | 2.15B | 209.74M | 10.81% |
| Dec 31, 2022 | 1.94B | 160.39M | 9.01% |
| Dec 31, 2021 | 1.78B | 25.27M | 1.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BenQ Medical Technology | 5.25B |
| St.Shine Optical | 4.40B |
| Formosa Optical Technology | 3.98B |
| Pacific Hospital Supply | 2.47B |
| Bionime | 1.91B |
| Chi Sheng Pharma & Biotech | 1.36B |
| ICARES Medicus | 1.09B |
| Crystalvue Medical | 949.05M |